Stem Cell Stocks 4/26/09: The Week That Was

There has still been no signifcant action with the stem cell stocks. Cancer drugs were hot last week. This week, it's all about the swine flu. As a result, I don't anticipate much upward movement with these stocks this week.

Top Stem Cell Stock Performer(s) for Last Week:

- BioTime, Inc. (BTIM) = Up 25% for the week; This stock rose on word that Broadwood Partners, which is already one of BTIM's large share holders, purchased around 35,000 additional shares.

Worst Stem Cell Stock Performer(s) for Last Week:

- Geron Corp (GERN) = Down -9% for the week; No signicant news; The stock had been on a good run the past few weeks. This just looks like profit taking.

Stem Cell Stocks Current Price and % Up or Down 4/20/09 - 4/24/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.52; Up 3%
Aastrom Biosciences (ASTM) = Cur Price: $0.326; Down -8%
BioTime, Inc. (BTIM) = Cur Price: $2.17; Up 24%
Celgene Corp (CELG) = Cur Price: $39.86; Up 4%
Cytori Therapeutics (CYTX) = Cur Price: $1.79; Down -1%
Geron Corp (GERN) = Cur Price: $4.94; Down -9%
ThermoGenesis (KOOL) = Cur Price: $0.59; Down -4%
Osiris Therapeutics (OSIR) = Cur Price: $12.34; Down -4%
StemCell Inc. (STEM) = Cur Price: $1.62; Down -4%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.0995; Unchanged
Athersys Inc. (ATHX) = Cur Price: $0.80; Down -1%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.08; Unchanged
Bioheart Inc. (BHRT) = Cur Price: $0.69; Unchanged
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0057; Down -4%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $0.80; Up 14%
Neuralstem (CUR) = Cur Price: $1.18; Down -2%
International Stem Cell (ISCO.OB) = Cur Price: $0.525; Up 22%
LifeStem International (LSTM.OB) = Cur Price: $0.008; Down -11%
MultiCell Technologies (MCET.OB) = Cur Price: $0.01; Down -5%
Pluristem Therapeutics (PSTI) = Cur Price: $1.33; Unchanged
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.095; Down -5%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.041; Up 3%

Catalyst(s) for the Week:

The catalyst(s) for the week remain unchanged from last week.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- More Mutual fund distribution of funds originally allocated for Genentech. It will take quite a while to redistribute these dollars throughout the biotech sector

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.